What Cibus, Inc. does.

Cibus is a leading agricultural biotechnology company that primarily uses proprietary gene editing technologies to develop plant traits, which are specific genetic characteristics in the DNA of a plant’s seed. Plant traits, or characteristics, influence how a resulting plant functions and/or interacts with its environment. Cibus produces these edited plant traits by a unique process that is endeavoring to change the scale and speed of plant breeding for many major agricultural crops. Over the course of its history, Cibus has developed a proprietary time bound and predictable gene editing platform referred to as the Rapid Trait Development System™ ( RTDS ® ). This system allows Cibus to edit gene targets that are the basis of novel traits that can be integrated into Cibus’ customers’ best or elite seed genetics in as

little as one year. Cibus’ primary trait business opportunities continue to broaden as key jurisdictions around the world more closely align gene editing regulatory policies with those already in place for conventional breeding.

Cibus’ business operates within the global seed market, where management estimates that aggregate trait value across both genetically modified organism (GMO) and non-GMO seeds globally represents approximately $12.0 billion.

Revenue and profit, by fiscal year.

More on CBUS.

• Cibus, Inc. summary
• Cibus, Inc. financial statements
• Cibus, Inc. key metrics
• Cibus, Inc. health scores and style box
• Cibus, Inc. earnings
• Cibus, Inc. dividends
• Cibus, Inc. valuation
• Cibus, Inc. ownership and insiders
• Cibus, Inc. peers

Figures from Cibus, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.